Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04011163Phase 3Active, not recruiting
Phase 3, open-label, single-arm trial, sponsored by KK Women's and Children's Hospital. Primary endpoint: Incidence of a clinically significant bradypnoea. Started Mar 2021; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04011163.